 Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs
Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores
Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores True Colors Ltd repays its entire outstanding term loan
True Colors Ltd repays its entire outstanding term loan Mastek and KarbonWise Join Forces to Accelerate their Sustainability Vision
Mastek and KarbonWise Join Forces to Accelerate their Sustainability Vision AXISCADES Technologies Ltd. and Cilas S.A. announce Strategic Defense Partnership
AXISCADES Technologies Ltd. and Cilas S.A. announce Strategic Defense Partnership 
              The Board of Directors of Venus Remedies Ltd at its meeting held on February 08, 2017, has allotted 9,00,000 warrants fully convertible into equity shares to promoters on preferential basis.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.104.1 as compared to the previous close of Rs. 104.65. The total number of shares traded during the day was 7564 in over 150 trades.
The stock hit an intraday high of Rs. 106 and intraday low of 103.9. The net turnover during the day was Rs. 792759.